MLchartDataset catalogue

Trelstar

Term · Oncology and biomedicine · MLC-T-ONC-008887

A drug used to treat advanced prostate cancer. It is also being studied in the treatment of other types of cancer. Trelstar initially causes the pituitary gland to make more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), temporarily increasing testosterone levels in men. With continued use, Trelstar lowers the amount of LH and FSH the pituitary gland releases, leading to a drop in testosterone levels. Trelstar may slow or stop the growth of cancer cells that need testosterone to grow. It is a type of luteinizing hormone-releasing hormone (LHRH) agonist. Also called triptorelin pamoate.

Table 1. Record
IdentifierMLC-T-ONC-008887
FieldOncology and biomedicine
Synonymstriptorelin pamoate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008887",
  "term": "Trelstar",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat advanced prostate cancer. It is also being studied in the treatment of other types of cancer. Trelstar initially causes the pituitary gland to make more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), temporarily increasing testosterone levels in men. With continued use, Trelstar lowers the amount of LH and FSH the pituitary gland releases, leading to a drop in testosterone levels. Trelstar may slow or stop the growth of cancer cells that need testosterone to grow. It is a type of luteinizing hormone-releasing hormone (LHRH) agonist. Also called triptorelin pamoate.",
  "synonyms": [
    "triptorelin pamoate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/trelstar/"
}

Record 16,688 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.